In 2022, around 8% of patients survived 30 days after a cardiac arrest
In 2022, around 8% of patients survived 30 days after a cardiac arrest
The diagnostic system can deliver particles to the lungs via aerosol or a nebuliser
The partnership will advance VTP-500 from early development to phase 2 clinical trials
The £30m ADVANCE study is the most extensive study into liver disease worldwide
The fertilised eggs could cultivate tumours for imaging within seven days
Both aim to advance the use of AI-powered cell analysis for cancer, stem cell and cell therapies
The nine-week DTxl CBT helps to address psychological symptom burdens in PF patients
Over a three-month period, 57% of patients using the app remained sober
Vd1-gd T cells were effective in predicting positive responses to ICI therapy
The companies will aim to select targets, discover and develop new therapeutics
High amounts of disrupted sleep were found to affect memory and thinking performance
Metastatic cancer is estimated to be responsible for 90% of cancer deaths
The new hub will be located in the King’s Cross Knowledge Quarter, London
NaviCam ProScan is the first AI-assisted reading tool for gastrointestinal bleeding
The programme is the only remote, digital delivery nursing home training programme for dementia